APT Medical Inc. (SHA:688617)
246.24
+18.74 (8.24%)
Feb 27, 2026, 3:00 PM CST
APT Medical Revenue
In the year 2025, APT Medical had annual revenue of 2.58B CNY with 25.08% growth. APT Medical had revenue of 716.49M in the quarter ending December 31, 2025, with 32.44% growth.
Revenue
2.58B
Revenue Growth
+25.08%
P/S Ratio
12.42
Revenue / Employee
1.01M
Employees
2,915
Market Cap
32.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.58B | 518.13M | 25.08% |
| Dec 31, 2024 | 2.07B | 415.59M | 25.18% |
| Dec 31, 2023 | 1.65B | 434.19M | 35.71% |
| Dec 31, 2022 | 1.22B | 387.33M | 46.74% |
| Dec 31, 2021 | 828.69M | 349.25M | 72.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Yuyue Medical Equipment & Supply | 8.08B |
| Lepu Medical Technology (Beijing) | 6.26B |
| Shenzhen New Industries Biomedical Engineering | 4.55B |
| Autobio Diagnostics | 4.22B |
| Shandong Weigao Blood Purification Products | 3.70B |
| MGI Tech | 3.01B |
| Double Medical Technology | 2.48B |
| Jafron Biomedical | 2.04B |